Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,403 | -177,119 | -101,944 | -87,758 | -58,574 |
| Depreciation Amortization | 2,379 | 2,328 | 1,168 | 346 | 3,947 |
| Accounts receivable | -2,463 | -982 | -14 | 381 | 53,227 |
| Accounts payable and accrued liabilities | 14,801 | 6,454 | 76 | -14,158 | -20,969 |
| Other Working Capital | 14,238 | 2,659 | 402 | -10,231 | 31,079 |
| Other Operating Activity | -7,332 | 4,763 | 11,461 | 24,403 | -151,679 |
| Operating Cash Flow | $-178,780 | $-161,897 | $-88,851 | $-87,017 | $-142,969 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,347 | -49,473 | -69,752 | 37,592 | 268,000 |
| PPE Investments | -1,031 | -470 | -1,326 | -1,221 | 10,926 |
| Purchase Of Investment | N/A | N/A | N/A | -34,261 | -58,555 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 160,385 |
| Investing Cash Flow | $-15,378 | $-49,943 | $-71,078 | $2,110 | $380,756 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 49,961 | 48,868 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -11,700 | -216,580 |
| Common Stock Issued | 64 | 138,823 | 94,205 | 37,084 | 69,970 |
| Common Stock Repurchased | -1,730 | -824 | -864 | -2,675 | -1,026 |
| Other Financing Activity | 240,015 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $238,349 | $187,960 | $142,209 | $22,709 | $-147,636 |
| Beginning Cash Position | 22,465 | 46,345 | 64,065 | 126,263 | 36,112 |
| End Cash Position | 66,656 | 22,465 | 46,345 | 64,065 | 126,263 |
| Net Cash Flow | $44,191 | $-23,880 | $-17,720 | $-62,198 | $90,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -178,780 | -161,897 | -88,851 | -87,017 | -142,969 |
| Capital Expenditure | -1,031 | -470 | -1,326 | -1,221 | -87 |
| Free Cash Flow | -179,811 | -162,367 | -90,177 | -88,238 | -143,056 |